Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001925127 | SCV002171172 | uncertain significance | not provided | 2021-12-02 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 110 of the MLC1 protein (p.Asn110Ser). This variant is present in population databases (rs766524233, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with MLC1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002503543 | SCV002806779 | uncertain significance | Megalencephalic leukoencephalopathy with subcortical cysts 1 | 2021-12-21 | criteria provided, single submitter | clinical testing |